Litcius/Paper detail

Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12

Ji Hyun Park, Sang Hoon Chun, Yun‐Gyoo Lee, Hyun Chang, Keun‐Wook Lee, Hye Ryun Kim, Seong Hoon Shin, Ho Jung An, Kyoung Eun Lee, In Gyu Hwang, Myung‐Ju Ahn, Sung‐Bae Kim, Bhumsuk Keam

2020Journal of Cancer Research and Clinical Oncology22 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineHead and neck cancerHead and neck squamous-cell carcinomaOncologyHematologyCancerIncidence (geometry)Radiation therapyChemotherapyGastroenterologyOpticsPhysicsCancer Immunotherapy and BiomarkersHead and Neck Cancer StudiesLung Cancer Treatments and Mutations
Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 | Litcius